Focus: Flow Medical is a biotechnology company focused on interventional treatment solutions for pulmonary embolism, a life-threatening respiratory condition. The company operates as a specialized biotech player in the interventional pulmonary space.
Profile data last refreshed 8h ago · AI intelligence enriched 2mo ago
Stable — net +4 jobs in 30d
4 added, 0 removed. Backfill posture.
Flow Medical represents a speculative early-stage opportunity with unclear clinical progress and organizational scale—only pursue if mission alignment and founder reputation outweigh visibility gaps.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Flow Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Flow Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles